Natus Medical Inc Quick Ratio (NTUS) starting from the first quarter 2022 to first quarter 2021, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Quick Ratio
• Working Capital
• LT Debt to Equity
• Debt to Equity
• Leverage Ratio
• Tangible Leverage
• Interest Coverage
• Debt Coverage
• Work. Cap. Per Revenue
Natus Medical Inc  (NASDAQ: NTUS)

Natus Medical Inc's Quick Ratio

NTUS's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


Natus Medical Inc's Cash & cash equivalent grew by 11.5 % in the Q1 2022 sequentially, while Current Liabilities decreased, this led to improvement in Natus Medical Inc's Quick Ratio to 0.78, Quick Ratio remained below Natus Medical Inc average.

Within Medical Equipment & Supplies industry 181 other companies have achieved higher Quick Ratio than Natus Medical Inc in first quarter 2022. While Quick Ratio total ranking in the first quarter 2022 has deteriorated compared to the prior quarter from 1244 to 3047.

Explain Quick Ratio?
How much Cash & cash equivalents NTUS´s has?
What are NTUS´s Current Liabilities?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

NTUS Quick Ratio (Mar 31 2022)
Q1		 (Dec 31 2021)
Q4		 (Sep 30 2021)
Q3		 (Jun 30 2021)
Q2		 (Mar 31 2021)
Q1
Y / Y Current Liabilities Change 21.12 % 3.39 % 6.66 % -39.95 % -7.71 %
Y / Y Cash & cash equivalent Change 4.64 % -7.9 % -7.72 % -26.37 % -24.73 %
Quick Ratio MRQ 0.78 0.69 0.7 1.11 0.9
NTUS's Total Ranking # 3047 # 1244 # 2361 # 2368 # 3340
Seq. Current Liabilities Change -1.15 % 11.16 % 75.63 % -37.23 % -15.62 %
Seq. Cash & cash equivalent Change 11.5 % 9.91 % 10.06 % -22.41 % -1.87 %



Quick Ratio first quarter 2022 Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 182
Healthcare Sector # 1003
Overall Market # 3047


Quick Ratio Statistics
High Average Low
3.1 0.82 0.21
(Dec 31 2016)   (Sep 30 2012)




Financial Statements
Natus Medical Inc's Current Liabilities $ 108 Millions Visit NTUS's Balance sheet
Natus Medical Inc's Cash & cash equivalent $ 84 Millions Visit NTUS's Balance sheet
Source of NTUS's Sales Visit NTUS's Sales by Geography


Cumulative Natus Medical Inc's Quick Ratio

NTUS's Quick Ratio for the trailling 12 Months

NTUS Quick Ratio

 (Mar 31 2022)
12 Months		 (Dec 31 2021)
12 Months		 (Sep 30 2021)
12 Months		 (Jun 30 2021)
12 Months		 (Mar 31 2021)
12 Months
Y / Y Current Liabilities TTM Growth -2.28 % -9.02 % -5.79 % -8.72 % 2.64 %
Y / Y Cash & cash equivalent TTM Growth -9.59 % -17.53 % -10.86 % -5.84 % 12.85 %
Quick Ratio TTM 0.78 0.81 0.84 0.87 0.84
Total Ranking TTM # 5906 # 5917 # 5924 # 5366 # 5928
Seq. Current Liabilities TTM Growth 5.34 % 1.03 % 1.79 % -9.79 % -1.92 %
Seq. Cash & cash equivalent TTM Growth 1.3 % -2.21 % -1.92 % -6.95 % -7.59 %

Quick ratio ranking by company, industry and sector >> Back to NTUS Financial Strength Comparisons >> Go to Compare NTUS Quick Ratio to its Competitors

On the trailing twelve months basis Due to decrease in Current Liabilities in the Q1 2022 to $108.37 millions, cumulative Quick Ratio decreased to 0.78 below the Natus Medical Inc average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Equipment & Supplies industry 255 other companies have achieved higher Quick Ratio than Natus Medical Inc. While Quick Ratio overall ranking has improved so far to 5906, from total ranking during the twelve months ending fourth quarter 2021 at 5917.

Explain Quick Ratio?
How much Cash & cash equivalents NTUS´s has?
What are NTUS´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Medical Equipment & Supplies Industry # 256
Healthcare Sector # 1238
Within the Market # 5906


trailing twelve months Quick Ratio Statistics
High Average Low
1.72 0.88 0.43
(Sep 30 2017)   (Dec 31 2019)




Companies with similar Quick Ratio in the quarter ending Mar 31 2022, within Medical Equipment & Supplies Industry Quick RatioMar 31 2022 MRQ Cash & cash equivalentMar 31 2022 MRQ Current Liabilities
Inspiremd Inc   2.11 $ 7.798  Millions$ 3.691  Millions
Mimedx Group Inc   2.07 $ 75.676  Millions$ 36.591  Millions
Icad Inc  2.06 $ 29.798  Millions$ 14.461  Millions
Orasure Technologies Inc  2.02 $ 112.224  Millions$ 55.587  Millions
Electromed Inc   1.98 $ 9.844  Millions$ 4.966  Millions
Si bone inc   1.93 $ 27.329  Millions$ 14.167  Millions
Venus Concept Inc   1.92 $ 17.911  Millions$ 9.322  Millions
Harpoon Therapeutics Inc   1.92 $ 112.465  Millions$ 58.583  Millions
Penumbra Inc  1.85 $ 240.341  Millions$ 130.099  Millions
Bioplus Acquisition Corp   1.85 $ 0.443  Millions$ 0.240  Millions
Warby Parker Inc   1.79 $ 230.324  Millions$ 128.742  Millions
Agape Atp Corporation  1.76 $ 2.442  Millions$ 1.391  Millions
Zynex inc   1.75 $ 39.247  Millions$ 22.368  Millions
Globus Medical Inc   1.72 $ 243.505  Millions$ 141.491  Millions
Cerus Corporation  1.63 $ 108.557  Millions$ 66.659  Millions
Surgalign Holdings Inc   1.58 $ 44.677  Millions$ 28.346  Millions
Edwards Lifesciences Corporation  1.57 $ 1,495.900  Millions$ 949.900  Millions
T2 Biosystems Inc   1.57 $ 19.386  Millions$ 12.335  Millions
Embecta Corp   1.56 $ 264.300  Millions$ 168.900  Millions
Biolife Solutions Inc   1.54 $ 59.463  Millions$ 38.543  Millions
Retractable Technologies Inc  1.49 $ 43.110  Millions$ 28.993  Millions
Privia Health Group Inc   1.45 $ 315.928  Millions$ 217.442  Millions
Dror Ortho-Design, Inc.  1.44 $ 0.147  Millions$ 0.102  Millions
Livanova Plc  1.44 $ 442.384  Millions$ 307.914  Millions
Lyra Therapeutics Inc   1.41 $ 33.755  Millions$ 23.989  Millions
Nuo Therapeutics Inc   1.40 $ 0.665  Millions$ 0.476  Millions
Strata Skin Sciences Inc  1.37 $ 10.923  Millions$ 7.979  Millions
Viveve Medical Inc   1.37 $ 14.045  Millions$ 10.263  Millions
Renovacare Inc   1.35 $ 1.878  Millions$ 1.387  Millions
Bionik Laboratories Corp   1.33 $ 1.991  Millions$ 1.492  Millions

Date modified: 2026-09-26T07:17:21+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.